Govorestat, First and Only Potential Treatment for Classic Galactosemia, Does Not Receive FDA Approval
Press Releases
Galactosemia Foundation  
November 27, 2024

Govorestat, First and Only Potential Treatment for Classic Galactosemia, Does Not Receive FDA Approval

Galactosemia Foundation Urges FDA to Reconsider on Behalf of Rare Disease Community Facing Devastating Disease

logo salamanca press

Salamanca Press

Local & Social